TFF Pharmaceuticals, Inc. (TFFP)

TFF Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.89	0.73	0.5	0.09	0	0
Revenue Growth (YoY)	84.60%	48.02%	462.39%	-	-	-
Gross Profit	0.89	0.73	0.5	0.09	0	0
Selling, General & Admin	9.89	10.57	13.8	10.57	8.01	3.17
Research & Development	11.6	12.06	18.5	21.3	10.68	8.82
Operating Expenses	21.48	22.63	32.29	31.87	18.69	11.99
Operating Income	-20.6	-21.89	-31.8	-31.79	-18.69	-11.99
Other Expense / Income	-0.67	-0.65	-0.03	-0.75	-0.13	-0.12
Pretax Income	-19.93	-21.24	-31.77	-31.04	-18.57	-11.87
Net Income	-19.93	-21.24	-31.77	-31.04	-18.57	-11.87
Preferred Dividends	0	0	0	0	0	24.81
Net Income Common	-19.93	-21.24	-31.77	-31.04	-18.57	-36.68
Shares Outstanding (Basic)	2	2	1	1	1	0
Shares Outstanding (Diluted)	2	2	1	1	1	0
Shares Change	64.94%	49.48%	20.78%	21.52%	195.80%	98.20%
EPS (Basic)	-9.75	-11.85	-26.49	-31.25	-22.75	-132.75
EPS (Diluted)	-9.75	-11.85	-26.49	-31.25	-22.75	-132.75
Free Cash Flow	-14.91	-16.13	-28.89	-30.43	-17.72	-11.22
Free Cash Flow Per Share	-6.25	-9.00	-24.09	-30.64	-21.69	-40.61
Gross Margin	100.00%	100.00%	100.00%	100.00%	-	-
Operating Margin	-2325.70%	-2983.45%	-6413.16%	-36055.24%	-	-
Profit Margin	-2249.82%	-2894.68%	-6407.77%	-35206.85%	-	-
Free Cash Flow Margin	-1683.55%	-2198.34%	-5827.59%	-34511.26%	-	-
EBITDA	-19.41	-20.74	-31.38	-30.93	-18.57	-11.87
EBITDA Margin	-2191.17%	-2826.21%	-6329.47%	-35080.43%	-	-
Depreciation & Amortization	0.52	0.5	0.39	0.11	0	0
EBIT	-19.93	-21.24	-31.77	-31.04	-18.57	-11.87
EBIT Margin	-2249.82%	-2894.68%	-6407.77%	-35206.85%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).